Postoperative Pain Control Following Hysteroscopy

Launched by AFYONKARAHISAR HEALTH SCIENCES UNIVERSITY · May 16, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of a medication called lidocaine, which is given during a procedure known as hysteroscopy, to see if it can help reduce pain, nausea, and the need for stronger pain medications after the surgery. Hysteroscopy is commonly performed to address issues like abnormal bleeding or growths in the uterus. The goal is to find out if using lidocaine can make recovery easier for patients by minimizing these uncomfortable side effects.

To participate in this trial, women aged 18 and older who are scheduled for an elective hysteroscopy may be eligible, provided they are generally healthy and not experiencing severe health issues. Participants will receive lidocaine during their procedure and will be monitored for any changes in pain or nausea after the surgery. This study aims to enhance the care and comfort of women undergoing this common gynecological procedure, ultimately leading to a quicker and smoother recovery.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Female patients with ASA I-II according to the American Society of Anesthesiologists (ASA) classification who are scheduled for elective hysteroscopy with indications such as
• • abnormal uterine bleeding
• • endometrial polyp
• • submucosal myoma
• • foreign body in the endometrial cavity
• • infertility
• • intrauterine synechia
• Exclusion Criteria:
• • Patients under the age of 18
• • Who are allergic to lidocaine addicted to opioids or NSAIDs
• • Patients with chronic pain
• • Patients with severe systemic disease
• • Patients who do not approve